Catalyst Wire Dossier Catalyst Wire Dossier

Ixekizumab

ixekizumab · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for Ixekizumab, covering 2014-09-16 to 2026-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]

See pricing